Defining the Critical Valency of Peptide-MHC on Nanoscale Artificial Antigen Presenting Cells for Expanding Endogenous Tumor-Specific T-cells In Vivo
Source abstract
Abstract
Expanding tumor antigen-specific T-cells in vivo remains a major challenge in developing effective cancer immunotherapeutics. Artificial antigen-presenting cells (aAPCs) have the potential to overcome this challenge, but formulating aAPCs without correlating the in vivo dynamics of T-cell expansion often leads to suboptimal T-cell responses. Here, we have defined the critical effect of the peptide-major histocompatibility complex (p-MHC) valency displayed along with co-stimulatory molecules on iron-oxide nanoparticle-based aAPCs in vivo and demonstrated that the functionality of these aAPCs is governed by the p-MHC valency. Nanoscale aAPCs engage cognate CD8+ T-cells directly to induce the formation of T-cell receptor (TCR) microclusters, leading to nuclear translocation of nuclear factor of activated T-cells (NFAT) in a p-MHC valency-dependent manner. Nanoscale aAPCs, presenting p-MHCs above the threshold valencies, promoted the expansion and tumor infiltration of adoptively transferred and endogenous tumor-specific CD8+ T-cells in tumor situations. The treatment effectively inhibited tumor growth, highlighting the importance of defining the threshold valency of p-MHC in developing aAPCs for effective immunotherapies.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Immunotherapy and Immune Responses · CAR-T cell therapy research · T-cell and B-cell Immunology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Nano-Biotechnology Laboratory
National Institute of Immunology
Department of Electrical Engineering, National Institute of Technology-Durgapur, Mahatma Gandhi Avenue, Durgapur, West Bengal 713209, India
TANLUN Medical Research and Innovation Inc., #6, XIERQIZHONGLU, Haidian District, Beijing 80086, China
Funding
Indian Council of Medical Research · Science and Engineering Research Board · Department of Biotechnology, Ministry of Science and Technology, India · National Institute of Immunology
References (36)
Show source-provided references
1. 10.1038/s41467-021-25282-310.1038/s41467-021-25282-3 ↗
2. 10.1073/pnas.24260009910.1073/pnas.242600099 ↗
3. 10.1038/s41422-022-00627-910.1038/s41422-022-00627-9 ↗
4. 10.1007/s10517-022-05451-010.1007/s10517-022-05451-0 ↗
5. 10.1021/acsnano.4c0055010.1021/acsnano.4c00550 ↗
6. 10.1038/nature2550110.1038/nature25501 ↗
7. 10.1038/s41467-017-01062-w10.1038/s41467-017-01062-w ↗
8. 10.1016/0022-1759(90)90210-M10.1016/0022-1759(90)90210-M ↗
9. 10.1021/acsnano.2c0621110.1021/acsnano.2c06211 ↗
10. 10.1038/nm86910.1038/nm869 ↗
11. 10.1038/s41596-019-0249-010.1038/s41596-019-0249-0 ↗
12. 10.1021/acsnano.5b0282910.1021/acsnano.5b02829 ↗
13. 10.3324/haematol.1252110.3324/haematol.12521 ↗
14. 10.1021/acssynbio.8b0011910.1021/acssynbio.8b00119 ↗
15. 10.1021/nl080332i10.1021/nl080332i ↗
16. 10.1186/1479-5876-8-10410.1186/1479-5876-8-104 ↗
17. 10.3389/fimmu.2022.100919810.3389/fimmu.2022.1009198 ↗
18. 10.7554/eLife.6561510.7554/eLife.65615 ↗
19. 10.1021/acsnano.2c1188410.1021/acsnano.2c11884 ↗
20. 10.1021/acs.nanolett.7b0373410.1021/acs.nanolett.7b03734 ↗
21. 10.1021/nn405520d10.1021/nn405520d ↗
22. 10.1158/2326-6066.CIR-18-088110.1158/2326-6066.CIR-18-0881 ↗
23. 10.1038/mt.2008.1110.1038/mt.2008.11 ↗
24. 10.1038/nnano.2014.15410.1038/nnano.2014.154 ↗
25. 10.1136/jitc-2023-00684710.1136/jitc-2023-006847 ↗
26. 10.1038/nbt.404710.1038/nbt.4047 ↗
27. 10.1038/nnano.2017.5610.1038/nnano.2017.56 ↗
28. 10.1073/pnas.160743611310.1073/pnas.1607436113 ↗
29. 10.1016/j.immuni.2006.04.01010.1016/j.immuni.2006.04.010 ↗
30. 10.1038/s41598-019-55286-510.1038/s41598-019-55286-5 ↗
31. 10.1038/s41467-019-09893-510.1038/s41467-019-09893-5 ↗
32. 10.1093/intimm/dxq44310.1093/intimm/dxq443 ↗
33. 10.1016/S1074-7613(00)80490-210.1016/S1074-7613(00)80490-2 ↗
34. 10.1038/nature0339110.1038/nature03391 ↗
35. 10.4049/jimmunol.178.5.275510.4049/jimmunol.178.5.2755 ↗
36. 10.1016/j.jconrel.2021.08.04310.1016/j.jconrel.2021.08.043 ↗